drug
nitisinone
Marketedupdated 4mo agoby Sobi Inc
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying nitisinone
Patent cliff
source: FDA Orange Bookfirst barrier falls
Feb 28, 2033
~6.5 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (4)
- Jan 5, 2035formulationUS 10328029
- Jan 5, 2035formulationUS 10328029
- Jan 5, 2035formulationUS 10328029
- Feb 28, 2033formulationUS 9301932
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 13m ago
Found something off?
comments(0)
5-min edit window · permanent after that